Long-Term Surveillance of Ocrelizumab-Treated Patients With Multiple Sclerosis (MANUSCRIPT Study)

28/02/2019
10/09/2026
EU PAS number:
EUPAS28619
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol BA39730 ocrelizumab Final v1_approved_Redacted

English (1.86 MB - PDF) View document
Updated protocol

BA39730-Protocol v2_OCREVUS_Redacted.pdf

First published: 08/09/2026
English (1.65 MB - PDF) View document

Prot BA39730 ocrelizumab v1, Published_Redacted

First published: 22/02/2024
English (1.87 MB - PDF) View document
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.